Viewing Study NCT01335451


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-06-15 @ 11:43 AM
Study NCT ID: NCT01335451
Status: COMPLETED
Last Update Posted: 2015-01-28
First Post: 2011-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese Subjects
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD5213 View
None safety View
None pharmacokinetics View
None single dose View
None repeated dose View
None young View
None elderly View
None Japanese View
None healthy subject View